Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3660449014 | Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3660450014 | Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Is a | Product containing phenyltoloxamine (medicinal product) | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Has active ingredient | Phenyltoloxamine (substance) | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Is a | Product containing phenylephrine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Has active ingredient | Chlorphenamine | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Has manufactured dose form | Prolonged-release oral capsule | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Is a | Product containing chlorphenamine and phenylephrine (medicinal product) | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Has active ingredient | Phenylephrine (substance) | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Is a | Chlorphenamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR